FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (VistaPharm, LLC)

View source ↗

Summary

FDA granted a supplemental approval for Mycophenolate mofetil from VistaPharm, LLC under ANDA210370.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Organ Transplant Rejection

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)